Complications Associated with PTCA

  • Gerald Dorros
  • Michael Cowley

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has proven to be a safe and effective treatment of selected patients with coronary artery occlusive disease. Initially, PTCA was used to treat proximal, isolated coronary stenosis in patients with single-vessel disease [1]. Subsequently, the technique of PTCA has been used as an investigative technique in patients with more complex coronary artery disease (e.g., when there is a history of prior bypass surgery, multivessel coronary disease, disease in geriatric patients, and disease necessitating multiple dilatations). In March 1979, the United States National Heart, Lung, and Blood Institute (NHLBI) established an international registry of PTCA patients. The purpose of the registry was to accumulate baseline and followup data to facilitate evaluation of the safety, effectiveness, and long-term outcome of this technique. In 1981, the initial report of the NHLBI PTCA Registry [2] discussed coronary angioplasty in general, and a subsequent communication in 1983 [3] concerned the complications occurring in the first 1500 patients enrolled in the Registry. The complication report was subsequently modified by reports [4–6] analyzing the complications which occurred in the 3079 patients from 105 contributing centers enrolled in the PTCA Registry. This communication will summarize the NHLBI PTCA Registry complications data, with particular emphasis on analysis of the acute coronary vascular and ischemic events, the inpatient mortality, and the patients who underwent emergency bypass surgery.

Keywords

Cholesterol Catheter Ischemia Heparin Nitrite 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gruentzig AR, Senning A, Siegenthaler WE (1979) Nonoperative dilatation of coronary artery stenosis. Percutaneous transluminal coronary angioplasty. N Engl J Med 301:61–68CrossRefGoogle Scholar
  2. 2.
    Kent KM, Bentivoglio LG, Block PC, Cowley MJ, Dorros G, Gosselin AJ, Gruentzig A, Myler RK, Simpson J, Stertzer SH, Williams DO, Fisher L, Gillespie MJ, Mullin SM, Mock MB (1981) Percutaneous transluminal coronary angioplasty: report from the NHLBI registry. Am J Cardiol 47:2100–2020Google Scholar
  3. 3.
    Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, Detre K, Gosselin AJ, Gruentzig AR, Kelsey SF, Kent KM, Mock MB, Mullin SM, Myler RK, Passamani ER, Stertzer SH, Williams DO (1983) Percutaneous transluminal coronary angioplasty: report of complications from the national heart, lung and blood institute PTCA registry. Circulation 67:723–730PubMedCrossRefGoogle Scholar
  4. 4.
    Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM (1984) Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 53:12C–16CPubMedCrossRefGoogle Scholar
  5. 5.
    Dorros G, Cowley MJ, Janke L, Kelsey SF, Mullin SM, Van Raden M (1984) In-hospital mortality rate in the National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Am J Cardiol 53:17C–21CPubMedCrossRefGoogle Scholar
  6. 6.
    Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM (1984) Emergency coronary bypass surgery after coronary angioplasty: the national heart, lung and blood institute’s percutaneous transluminal coronary angioplasty registry experience. Am J Cardiol 53:22C–26CPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Gerald Dorros
  • Michael Cowley

There are no affiliations available

Personalised recommendations